Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Dr. Martin P.
Mexico
USD 50 /hr
Pharmaceutical Patent Analyst | Scientific Information Analyst (patents, scientific publications, clinical trials)
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing
Research
Market Research,
Feasibility Study,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis
Work Experience
Work information not provided.
Education
Education details not provided.
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Martin Perez-Santos, Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz, Diana Barron-Villaverde (2023). Drug repurposing of Mito-Atovaquone for cancer treatment . Pharmaceutical Patent Analyst.
Cindy Bandala, Eleazar Lara-Padilla, Noemí Cárdenas-Rodríguez, Samuel Reyes-Long, Alfredo Cortés-Algara, Itzel Jatziri Contreras-García, Teresita Rocío Cruz-Hernández, Alfonso Alfaro-Rodriguez, José Luis Cortes-Altamirano, Martín Perez-Santos, et al.(2023). Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19 . Current Neuropharmacology. 21. Bentham Science Publishers Ltd.
Martin Perez-Santos, Gabriela Sanchez-Esgua, Juan Reyes-Alvarez (2023). Patenting trends in the pharmaceutical field of Mexican universities . Pharmaceutical Patent Analyst.
Martin Perez-Santos, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz, Gabriela Sánchez Esgua (2022). Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents . Expert Opinion on Drug Discovery.
Luis Villafaña-Díaz, Margarita Tecpoyotl-Torres, Martín Perez-Santos, Diana Barrón-Villaverde (2022). Evaluación tecnológica y comercial de patentes universitarias a partir de la identificación de oportunidades comerciales en transferencia de tecnología . CienciaUAT.
(2022). Vigilancia tecnológica: una perspectiva global del comportamiento de patente en coronavirus del 2001 al 2021. Revista Internacional de Investigación e Innovación Tecnológica.
Martin Perez-Santos, Viridiana I Flores-Quiroz, Lino Zumaquero-Ríos(2022). Pharmaceutical agents for the treatment of Chagas disease: patenting trends in the 2016–2021 period . Pharmaceutical Patent Analyst. Future Science Ltd
Martin Perez-Santos, Maricruz Anaya-Ruiz(2022). Drug repurposing of adapalene for melanoma treatment . Pharmaceutical Patent Analyst. 11. (1). p. 9--14. Future Science Ltd
Martin Perez-Santos, Maricruz Anaya-Ruiz(2021). Small-molecule inhibitor PD-1/PD-L1 interaction for colorectal cancer treatment . Pharmaceutical Patent Analyst. 10. (6). p. 245--250. Future Science Ltd
(2021). Neurophysiological Mechanisms Related to Pain Management in Bone Tumors . Current Neuropharmacology.
Martin Perez-Santos(2021). Bispecific anti-OX40/5T4 antibodies for cancer treatment . Pharmaceutical Patent Analyst. 10. (2). p. 59--66. Future Science Ltd
Martin Perez-Santos, Maricruz Anaya-Ruiz, Gabriela Sanchez-Esgua, Luis Villafaña-Diaz, Diana Barron-Villaverde(2021). Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody . Pharmaceutical Patent Analyst. 10. (2). p. 67--72. Future Science Ltd
Martin Perez-Santos, Jorge Cebada, Cindy Bandala, Eleazar Lara-Padilla, Irma Herrera-Camacho, Nora Hilda Rosas-Murrieta, Lourdes Millán-Pérez Peña, Eduardo Monjaraz, Amira Flores, Maricruz Anaya-Ruiz(2021). OX40 agonists for cancer treatment: a patent review . Expert Opinion on Therapeutic Patents. 31. (1). p. 81--90. Informa {UK} Limited
Martin Perez-Santos, Nemesio Villa-Ruano, Tayde Guerrero-González, Eduardo Gómez-Conde(2020). Bispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232 . Expert Opinion on Therapeutic Patents. 30. (10). p. 723--727. Informa {UK} Limited
Martin Perez-Santos(2020). Bispecific anti-PD-1/CTLA-4 antibody for advanced solid tumors . Pharmaceutical Patent Analyst. 9. (5). p. 149--154. Future Science Ltd
Martin Perez-Santos, Jorge Cebada, Amira Flores, Cindy Bandala, Ian Lizaliturri-Flores, Nemesio Villa-Ruano(2020). Bispecific anti-PD-1/LAG-3 antibodies for treatment of advanced or metastatic solid tumors: a patent evaluation of US2018326054 . Expert Opinion on Therapeutic Patents. 30. (7). p. 487--494. Informa {UK} Limited
(2020). miRNA let-7b inhibitors by treatment of diabetic retinopathy: evaluation patent US2019093106 . Alianzas y Tendencias.
Perez-Santos Martin, Lourdes Millán-Pérez Peña, Irma Herrera-Camacho, Cindy Bandala, Maricruz Anaya-Ruiz(2020). Colon carcinoma treatment using bispecific anti-GITR/CTLA-4 antibodies: a patent evaluation of WO2018091739 . Expert Opinion on Therapeutic Patents. p. 1--5. Informa {UK} Limited
(2020). Evaluation of US2019070266 patent, treatment diabetic foot ulcers with Liraglutide . Alianzas y Tendencias.
Martin Perez-Santos, Tayde Guerrero-González, Eduardo Gómez-Conde, Jorge Cebada, Amira Flores, Nemesio Villa-Ruano(2020). Treatment of cancer with an anti-KIR antibody: a patent evaluation of US9879082 and US2018208652 . Expert Opinion on Therapeutic Patents. 30. (3). p. 159--162. Informa {UK} Limited
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho, Nora Hilda Rosas-Murrieta, Lourdes Millán-Pérez Peña(2020). Cancer combinatorial immunotherapy using etigilimab and nivolumab: a patent evaluation of WO2018102536 . Expert Opinion on Therapeutic Patents. 30. (2). p. 83--86. Informa {UK} Limited
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho, Lourdes Millán-Pérez Peña, Nora Hilda Rosas-Murrieta(2019). Bispecific anti-OX40/CTLA-4 antibodies for advanced solid tumors: a patent evaluation of WO2018202649 . Expert Opinion on Therapeutic Patents. p. 1--4. Informa {UK} Limited
Martin Perez-Santos, Irma Herrera-Camacho, Maricruz Anaya-Ruiz, Lourdes Millán-Pérez Peña, Cindy Bandala, Gerardo Landeta(2019). Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1 . Expert Opinion on Therapeutic Patents. 29. (8). p. 587--593. Informa {UK} Limited
Martin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales, Nemesio Villa-Ruano(2019). LAG-3 antagonists by cancer treatment: a patent review . Expert Opinion on Therapeutic Patents. 29. (8). p. 643--651. Informa {UK} Limited
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho, Lourdes Millán-Pérez Peña(2019). Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1 . Expert Opinion on Therapeutic Patents. 29. (7). p. 481--485. Informa {UK} Limited
Martin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, Irma Herrera-Camacho(2019). Treatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1 . Expert Opinion on Therapeutic Patents. p. 1--4. Informa {UK} Limited
(2018). Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents An Increasing Interest in Nanoparticles in Cancer . Recent Patent on Anti-Cancer Drug Discovery.
(2018). Emerging Drugs for the Treatment of Breast Cancer Brain Metastasis: A Review of Patent Literature . Recent Patents on Anti-Cancer Drug Discovery.
(2018). Bursera copallifera Extracts Have Cytotoxic and Migration-Inhibitory Effects in Breast Cancer Cell Lines . Integrative Cancer Therapies.
(2018). Patent and Publications Trends in Breast Cancer Chemotherapy. Archives of Oncology and Cancer Therapy.
(2018). Global Patent Landscape in Breast Cancer Metastasis. Acta Scientific Cancer Biology.
(2018). Patent highlights in cancer gene therapy's. Acta Scientific Cancer Biology.
(2017). Contribución de México a la investigación en diabetes tipo-2: un análisis bibliométrico 2011-2015 . Alianzas y Tendencias.
Mart{\'i}nez-Montiel, N. and Anaya-Ruiz, M. and P{\'e}rez-Santos, M. and Mart{\'i}nez-Contreras, R.D.(2017). Alternative splicing in breast cancer and the potential development of therapeutic tools . Genes. 8. (10).
(2017). Úlcera de pie diabético: mapeo de publicaciones científicas y patentes . Alianzas y Tendencias.
(2017). Metastasis Breast Cancer Output Research. EC Gynaecology.
(2017). Mapping Publications and Patents in Breast Cancer Immunotherapy. Acta Scientific Cancer Biology.
Perez-Santos, Martin and Anaya-Ruiz, Maricruz and Bandala, Cindy(2017). Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents . Recent Patents on Anti-Cancer Drug Discovery. 12. (1). p. 81-93.
Perez-Santos, Martin, Anaya-Ruiz, Maricruz, Bandala, Cindy(2017). Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents . Recent Patents on Anti-Cancer Drug Discovery. 12. (1). p. 81-93.
Perez-Santos, M., Anaya-Ruiz, M., Bandala, C.(2017). Contribution of latin american countries to cancer research and patent generation: Recent patents . Recent Patents on Anti-Cancer Drug Discovery. 12. (1). p. 81-93.
Zumaquero-Ríos, J.L., Pérez-Santos, M., Villa-Mancera, A., Sarracent-Pérez, J.(2017). Immunization with excretion-secretion products of Trichinella spiralis combined to CTLA-4 blockade produces a high degree of protection against a challenge with the parasite | La inmunización con productos de excreción-secreción de Trichinella spiralis unido al bloqueo de CTLA-4 produce un elevado grado de protección ante un reto con el parásito . VacciMonitor. 26. (1). p. 24-30.
Cort{\'e}s-Algara, A. and C{\'a}rdenas-Rodr{\'i}guez, N. and Lara-Padilla, E. and Floriano-S{\'a}nchez, E. and Mart{\'i}nez-Contreras, R. and Anaya-Ruiz, M. and Uribe-Escamilla, R. and Alfaro-Rodr{\'i}guez, A. and Ilizaliturri-Flores, I. and P{\'e}rez-Santos, M. and Bandala, C.(2017). Synaptic vesicle protein isoforms (SV2A, SV2B, SV2C): Expression in breast cancer and their association with risk factors and metastasis in Mexican women . International Journal of Clinical and Experimental Pathology. 10. (2). p. 1998-2004.
Cortés-Algara, A., Cárdenas-Rodríguez, N., Lara-Padilla, E., Floriano-Sánchez, E., Martínez-Contreras, R., Anaya-Ruiz, M., Uribe-Escamilla, R., Alfaro-Rodríguez, A., Ilizaliturri-Flores, I., Pérez-Santos, M., et al.(2017). Synaptic vesicle protein isoforms (SV2A, SV2B, SV2C): Expression in breast cancer and their association with risk factors and metastasis in Mexican women . International Journal of Clinical and Experimental Pathology. 10. (2). p. 1998-2004.
Martínez-Montiel, N., Anaya-Ruiz, M., Pérez-Santos, M., Martínez-Contreras, R.D.(2017). Alternative splicing in breast cancer and the potential development of therapeutic tools . Genes. 8. (10).
(2016). Uso de microorganismos benéficos para reducir los daños causados por la revolución verde. Revista Iberoamericana de Ciencias.
(2015). Innovation Status of Gene Therapy for Breast Cancer . Asían Pacific Journal of Cancer Prevention.
Anaya-Ruiz, M., Perez-Santos, M.(2015). Innovation status of gene therapy for breast cancer . Asian Pacific Journal of Cancer Prevention. 16. (9). p. 4133-4136.
(2014). Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output . Asian Pacific Journal of Cancer Prevention.
(2014). Female Breast Cancer Incidence and Mortality in Mexico, 2000-2010 . Asian Pacific Journal of Cancer Prevention.
Anaya-Ruiz, M., Vallejo-Ruiz, V., Flores-Mendoza, L., Perez-Santos, M.(2014). Female breast cancer incidence and mortality in Mexico, 2000-2010 . Asian Pacific Journal of Cancer Prevention. 15. (3). p. 1477-1479.
Anaya-Ruiz, M., Vincent, A.K., Perez-Santos, M.(2014). Cervical cancer trends in Mexico: Incidence, mortality and research output . Asian Pacific Journal of Cancer Prevention. 15. (20). p. 8689-8692.
(2013). Mexican Breast Cancer Research Output, 2003-2012 . Asian Pacific Journal of Cancer Prevention.
(2013). miR-153 Silencing Induces Apoptosis in the MDA-MB-231 Breast Cancer Cell Line . Asian Pacific Journal of Cancer Prevention.
Anaya-Ruiz, M., Cebada, J., Delgado-López, G., Sánchez-Vázquez, M.L., Pérez-Santos, J.L.M.(2013). miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line . Asian Pacific Journal of Cancer Prevention. 14. (5). p. 2983-2986.
Bandala, C. and Perez-Santos, J.L.M. and Lara-Padilla, E. and Lopez, M.G.D. and Anaya-Ruiz, M.(2013). Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line . Asian Pacific Journal of Cancer Prevention. 14. (2). p. 891-894.
Bandala, C., Perez-Santos, J.L.M., Lara-Padilla, E., Lopez, M.G.D., Anaya-Ruiz, M.(2013). Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line . Asian Pacific Journal of Cancer Prevention. 14. (2). p. 891-894.
Anaya-Ruiz, M. and Bandala, C. and P{\'e}rez-Santos, J.L.M.(2013). MiR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells . Asian Pacific Journal of Cancer Prevention. 14. (6). p. 3757-3760.
Anaya-Ruiz, M., Bandala, C., Pérez-Santos, J.L.M.(2013). MiR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells . Asian Pacific Journal of Cancer Prevention. 14. (6). p. 3757-3760.
Perez-Santos, J.L.M., Anaya-Ruiz, M.(2013). Mexican breast cancer research output, 2003-2012 . Asian Pacific Journal of Cancer Prevention. 14. (10). p. 5921-5923.
(2003). An ecto-protein tyrosine phosphatase of Entamoeba histolytica induces cellular detachment by disruption of actin filaments in HeLa cells . International Journal for Parasitology.
Anaya-Ruiz, M., Pérez-Santos, J.L.M., Talamás-Rohana, P.(2003). An ecto-protein tyrosine phosphatase of Entamoeba histolytica induces cellular detachment by disruption of actin filaments in HeLa cells . International Journal for Parasitology. 33. (7). p. 663-670.
Ratings and Comments
Total Projects Awarded:
Comments:
